We need clarity on big pharma’s tax breaks | Letters
NeutralFinancial Markets

We need clarity on big pharma’s tax breaks | Letters
Mike Lewis, the outgoing CEO of GSK, emphasizes the need for greater transparency regarding the substantial tax breaks that pharmaceutical companies receive from the UK government. He argues that the NHS should increase its payments for drugs to foster a better commercial environment and enhance patient access to innovative treatments. This discussion is crucial as it highlights the balance between pharmaceutical profits and public health funding, impacting how future healthcare policies may be shaped.
— via World Pulse Now AI Editorial System




